Recombinant Technologies
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1090 Meriden Waterbury Tpke Ste 1, Chesh...Phone Number
(203) 271-3125Website
www.recombtech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Recombinant Technologies
Recombinant Technologies, LLC is an emerging biotechnology company dedicated to developing therapeutics for neurodegenerative diseases, particularly Alzheimer's disease. Their flagship product, AmyTrap, is a proprietary small molecule designed to alleviate symptoms associated with beta-amyloidopathies. The company aims to improve the quality of life for patients by utilizing innovative technologies, including the AmyTrapper plasma-filtration column. With over $2M invested in research and development, Recombinant Technologies is focused on addressing unmet medical needs in the field of neurodegenerative disorders.Explore more
Recombinant Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Recombinant Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Recombinant Technologies is spiking on competitors!
Funding: Get notified immidiatlly once Recombinant Technologies has new funding data
Recombinant Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Recombinant Technologies
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Recombinant Technologies recently announced quarterly report
Click to see if Recombinant Technologies had a recent Job posting/layoffs
Product Launch: Get notified when Recombinant Technologies launches new products
Check if Recombinant Technologies has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Recombinant Technologies as Masked Content
Find 2 more new buyers
Compare Similar Companies to Recombinant Technologies
Compare insights from companies similar to Recombinant Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Recombinant Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Recombinant Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Recombinant Technologies.
Recombinant Technologies Tech Stack
A closer look at the technologies used by Recombinant Technologies
See more technologies
Recombinant Technologies News & Media
Better Living for People With Alzheimer's: One of a Kind Device and Opportunity to Make a Difference
Recombinant Technologies, an innovative, preclinical stage biotechnology company (www.recombtech.com) from Cheshire, CT, has kickstarted a crowdf ...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Recombinant Technologies
Sign Up For FreeTo access detailed company insights
Recombinant Technologies, LLC is an emerging biotechnology company dedicated to developing therapeutics for neurodegenerative diseases, particularly Alzheimer's disease. Their flagship product, AmyTrap, is a proprietary small molecule designed to alleviate symptoms associated with beta-amyloidopathies. The company aims to improve the quality of lif... Read More
